Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design.
Pond GR, Bellmunt J, Fougeray R, Choueiri TK, Qu AQ, Niegisch G, Albers P, Di Lorenzo G, Salhi Y, Galsky MD, Agarwal N, Necchi A, Sonpavde G. Pond GR, et al. Among authors: galsky md. Clin Genitourin Cancer. 2013 Dec;11(4):495-500. doi: 10.1016/j.clgc.2013.04.025. Epub 2013 Jun 22. Clin Genitourin Cancer. 2013. PMID: 23800847
Problems with the randomized discontinuation design.
Sonpavde G, Hutson TE, Galsky MD, Berry WR. Sonpavde G, et al. Among authors: galsky md. J Clin Oncol. 2006 Oct 1;24(28):4669-70; author reply 4670-1. doi: 10.1200/JCO.2006.08.1026. J Clin Oncol. 2006. PMID: 17008711 No abstract available.
Germ-cell tumors.
Kondagunta V, Galsky MD, Sonpavde G. Kondagunta V, et al. Among authors: galsky md. N Engl J Med. 2007 Oct 25;357(17):1773; author reply 1773-4. N Engl J Med. 2007. PMID: 17969229 No abstract available.
Novel agents for muscle-invasive and advanced urothelial cancer.
Sonpavde G, Ross R, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Lerner SP, Sternberg CN. Sonpavde G, et al. Among authors: galsky md. BJU Int. 2008 Apr;101(8):937-43. doi: 10.1111/j.1464-410X.2007.07326.x. Epub 2007 Nov 13. BJU Int. 2008. PMID: 18005203 Review.
Current optimal chemotherapy for advanced urothelial cancer.
Sonpavde G, Galsky MD, Hutson TE. Sonpavde G, et al. Among authors: galsky md. Expert Rev Anticancer Ther. 2008 Jan;8(1):51-61. doi: 10.1586/14737140.8.1.51. Expert Rev Anticancer Ther. 2008. PMID: 18095883 Review.
Trial design for metastatic castration-resistant prostate cancer.
Sonpavde G, Fleming MT, Hutson TE, Galsky MD. Sonpavde G, et al. Among authors: galsky md. J Clin Oncol. 2008 Jul 20;26(21):3647-8; author reply 3648-9. doi: 10.1200/JCO.2008.17.1140. J Clin Oncol. 2008. PMID: 18640946 No abstract available.
405 results